Consultation - Maximum residue limit (MRL) proposal for Albendazole, Fenbendazole, Flunixin, Zilpaterol, Doramectin, Emamectin, Ivermectin, Moxidectin, Streptomycin, Dihydrostreptomycin and Gentamicin sulphate

The online consultation is now closed. The content found on this page is a snapshot of the live consultation as it was presented to the public and contains the content that was open for submissions during the consultation period.

The Veterinary Drugs Directorate (VDD) of Health Products and Food Branch, Health
Canada, is considering  regulatory amendment which may be of interest to you.  More specifically, the VDD is proposing to establish Maximum  Residue Limits (MRLs) in Table III Division 15, Part B of the Food and Drug Regulations for Albendazole, Fenbendazole, Flunixin, Zilpaterol, Doramectin, Emamectin, Ivermectin, Moxidectin, Streptomycin, Dihydrostreptomycin and Gentamicin sulfate in edible tissues of food-producing animals.

How to Get Involved

This consultation is open for comment starting December 16, 2009 until March 16, 2010. Please select and read through the link below titled “consultation document”. Once read please submit your comments via email, fax or by mail to:

ConsultationVDD-DMV@hc-sc.gc.ca

Consultations - Veterinary Drugs Directorate
Policy, Regulatory and International Affairs Division
Veterinary Drugs Directorate,
Health Products and Food Branch, Health Canada
Holland Cross Complex
11 Holland ave.
Ground Floor, Suite 14
Ottawa, Ontario
K1A 0K9

Fax: (613) 957-3861

Consultation Document

Interested parties are encouraged to provide comments and suggestions by March 16, 2010.

Reporting to Canadians

After careful consideration of the comments received from the 90-day consultation period, the proposed MRLs will be published in the Canada Gazette, Part I.

If you have any questions, contact us at ConsultationVDD-DMV@hc-sc.gc.ca